OAC
NUVB icon

OMERS Administration Corp’s Nuvation Bio NUVB Stock Holding History

OMERS Administration Corp’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-101,700
Closed -$376K – 1251
2025
Q3 		$376K Buy
+101,700
New +$277K ﹤0.01% 821

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

OMERS Administration Corp's NUVB Position: Q4 2025 in Review

OMERS Administration Corp sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 101,700 shares — an estimated $376K sold.

OMERS Administration Corp first reported a position in NUVB in Q3 2025 and held it in 1 quarter. The position peaked at $376K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • OMERS Administration Corp reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 101,700 Nuvation Bio shares in Q4 2025, an estimated $376K.
  • OMERS Administration Corp first reported a position in Nuvation Bio in Q3 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Nuvation Bio position peaked at $376K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.